Short answer
Cannabis is not an approved migraine treatment in the United States. The FDA has approved three cannabinoid drugs: Epidiolex for seizures, and dronabinol and nabilone for chemotherapy nausea. None list migraine as an indication. Some patients report fewer headache days. The trials behind that report are small and lack control groups. Talk to a clinician before you use it.
What the research shows
Observational data
A 2016 chart review in Pharmacotherapy followed 121 patients at a Colorado clinic. Monthly migraine days fell from 10.4 to 4.6. A 2019 survey in the Journal of Headache and Pain collected self-reports from 1,276 medical cannabis patients. Headache severity dropped 47.3 percent. Neither study used a placebo group. Patients who expect relief may report relief.
Weed for Migraines: How Much to Smoke
Clinical trials
Randomized trials are few. A 2019 trial tested two cannabis strains against placebo in 30 patients. Both strains cut pain intensity versus placebo. The sample was small. Reviews from headache societies rate the evidence as low quality. No trial has tested cannabis head to head against triptans or gepants.
Cannabis for Intractable Migraine Pain Management: A Comprehensive Guide
Product forms and onset times
- Inhalation (flower, vape): onset 3 to 10 minutes, duration 2 to 3 hours.
- Oral (edibles, capsules): onset 30 to 90 minutes, duration 4 to 8 hours.
- Sublingual tinctures and sprays: onset 15 to 45 minutes.
- Topicals: no psychoactive effect. Evidence for migraine is thin.
Dosing steps
- Start with THC under 2.5 mg, or a CBD-dominant product.
- Log headache days, severity, and dose.
- Wait 2 hours before a second oral dose.
- Do not mix with alcohol or sedatives.
- Review the log after 4 weeks.
Legal status and access
More than 35 states and the District of Columbia run medical cannabis programs. Migraine is not a qualifying condition in every state. Some states list migraine, some list chronic pain or severe headaches. A state card costs $25 to $100 and renews each year. Federal law lists cannabis as a Schedule I drug. That status limits research and blocks insurance coverage.
Side effects and risks
Common effects include drowsiness, dry mouth, impaired memory, and a faster heart rate. THC can trigger rebound headache in some users. NIDA reports about 3 in 10 people who use cannabis develop cannabis use disorder. Cannabis interacts with blood thinners, antidepressants, and seizure drugs. Do not drive after use.
Cost and convenience
Medical cannabis runs $150 to $500 per ounce in US dispensaries, based on state and product. Insurance does not pay. A monthly supply costs $50 to $300. Generic sumatriptan costs $10 to $30 per month with insurance. Convenience drives the choice for many patients. A vape pen works in 5 minutes. A tincture takes 45. A prescription pill requires a pharmacy trip and a prior authorization.
Talk to a clinician
Bring a headache diary to the visit. List current drugs. Ask about triptans, gepants, and CGRP antibodies first. Those have FDA approval for migraine and trial data behind them. Ask about cannabis as an add-on. Mention any history of substance use.